Forte Biosciences
FBRX
FBRX
30 hedge funds and large institutions have $11.1M invested in Forte Biosciences in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% less funds holding
Funds holding: 31 → 30 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
Holders
30
Holding in Top 10
–
Calls
$110K
Puts
$1K
Top Buyers
| 1 | +$2.4M | |
| 2 | +$2.16M | |
| 3 | +$1.97M | |
| 4 |
FAM
Fred Alger Management
New York
|
+$1.22M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$1.2M |
Top Sellers
| 1 | -$71.3K | |
| 2 | -$59.4K | |
| 3 | -$51.6K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$38.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31.5K |